-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...
-
Product Insights
Wound Closure Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Wound Closure Devices Pipeline Market Report Overview Wound closure devices are used to close wounds that occur due to injuries or surgical procedures. The Wound Closure Devices pipeline market research report provides comprehensive information about the Wound Closure Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report discusses the territories where the Wound Closure Devices pipeline market is present. It also provides...
-
Company Insights
TotalEnergies – Digital Transformation Strategies
TotalEnergies SE (Total), formerly known as Total SA, has been focusing on using artificial intelligence, blockchain, big data, IoT and drones to digitally transform its operations. The annual ICT spending of Total was estimated at $2.9 billion for 2022. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Total is an integrated multinational energy company with operations spanning the entire oil and gas chain from exploring and producing crude oil and natural...
-
Company Profile
Kuala Lumpur Kepong Bhd – Company Profile
Kuala Lumpur Kepong Bhd (KLK) is a producer of palm products and rubber. The company offers palm kernels, palm oil, non-ionic surfactants, and esters, oleochemicals, rubber gloves, pharmaceutical products, and parquet flooring products. Its products are used in variety of applications such as food and nutrition, lubricants, flavors and fragrances, home and personal care, industrial chemicals, and pharmaceuticals. The company is also involved in real-estate development business. It has plantations and manufacturing facilities in Malaysia, Indonesia, Liberia, Belgium, China, Indonesia,...
Add to Basket -
Company Profile
China National Chemical Corp – Company Profile
China National Chemical Corp (ChemChina) is a state-owned enterprise that develops and markets chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, petroleum processing and refining products, basic chemicals, and rubber products. It also manufactures equipment such as rubber machinery, ionic membrane electrolyzer, drying equipment and axle gear. The company also provides decision making consulting services for the chemical industry. ChemChina’s products find application in agriculture, aerospace, energy, automotive, construction, and pharmaceutical industries. The company has production, research and...
Add to Basket -
Product Insights
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Drugs Market Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation therapy....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HTD-1801
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HTD-1801 Drug Details HTD-1801 (berberine ursodeoxycholate) is under development for the treatment of primary...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – oxycodone
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry oxycodone Drug Details Oxycodone (MRX-1OXT) is under development for the treatment of moderate to...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – lidocaine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry lidocaine Drug Details lidocaine (MRX-5LBT) is under development for the treatment nerve pain associated...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – tizanidine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry tizanidine Drug Details Tizanidine (MRX-4TZT, CPN-101) is under development for the treatment of spastic...